Search results
Evolve Bank sent a cease and desist letter to a newsletter writer covering its data breach
TechCrunch· 21 minutes agoThe situation around a data breach that’s affected an ever-growing number of fintech companies has...
U.S. Awards $504 Million for ‘Tech Hubs’ in Overlooked Regions
New York Times· 28 minutes agoBiden administration officials hope the money will help propel technological innovation in areas that have historically received less government funding. The Biden administration on Tuesday ...
Paramount Stock Rises Over 5% Amid Renewed BET Network Sale Talks
The Wrap via Yahoo Finance Canada· 55 minutes agoA group that includes BET CEO Scott Mills and CC Capital's Chinh Chu is looking to offer between...
Paramount Global Stock Jumps On Report Of Revived BET Sale Talks
Deadline via Yahoo Finance Canada· 59 minutes agoParamount Global stock jumped 6% on Tuesday on the latest report the company has resumed talking to...
Lion Electric secures loan of up to $7.5M from Quebec
Montreal Gazette· 2 hours agoLion Electric Company announced a new agreement Tuesday with Investissement Québec for a loan of up...
Institutional investors own a significant stake of 49% in Oil-Dri Corporation of America (NYSE:ODC)
Simply Wall St. via Yahoo Finance Canada· 2 hours agoAnd the group that holds the biggest piece of the pie are institutions with 49% ownership. In other...
Lindsay Australia And 2 Other ASX Dividend Stocks To Watch
Simply Wall St. via Yahoo Finance Canada· 2 hours agoOver the past year, the Australian market has shown a steady increase of 7.5%, maintaining a flat...
Top 3 ASX Stocks Estimated To Be Trading Below Intrinsic Value In July 2024
Simply Wall St. via Yahoo Finance Canada· 2 hours agoAmidst a fluctuating Australian market, influenced by the Reserve Bank of Australia's contemplation...
Exploring ASX Dividend Stocks: Avoiding Lottery And Highlighting One Superior Option
Simply Wall St. via Yahoo Finance Canada· 2 hours agoIn the pursuit of reliable dividend income from ASX-listed companies, investors should be cautious...
Mean cost of bringing new drug to US market is $879.3 million, study estimates
Medical Xpress· 2 hours agoThe mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when...